Your browser doesn't support javascript.
loading
Advances in the management of pancreatic cancer.
Del Chiaro, Marco; Sugawara, Toshitaka; Karam, Sana D; Messersmith, Wells A.
Afiliação
  • Del Chiaro M; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Sugawara T; University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO, USA.
  • Karam SD; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
  • Messersmith WA; Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
BMJ ; 383: e073995, 2023 12 13.
Article em En | MEDLINE | ID: mdl-38164628
ABSTRACT
Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than other cancers. Multimodal treatment, including chemotherapy, surgical resection, and radiotherapy, has been under investigation for many years. Because of the anatomical characteristics of the pancreas, more emphasis on treatment selection has been placed on local extension into major vessels. Recently, the development of more effective treatment regimens has opened up new treatment strategies, but urgent research questions have also become apparent. This review outlines the current management of pancreatic cancer, and the recent advances in its treatment. The review discusses future treatment pathways aimed at integrating novel findings of translational and clinical research.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article